A carregar...

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare expenditure. In the United States, approximately 0.1 % of the population experiences an initial VTE event each year. Anticoagulation therapy is the cornerstone of acute VTE treatment and for prevention of recurrent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs
Main Authors: Dobesh, Paul P., Fanikos, John
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224738/
https://ncbi.nlm.nih.gov/pubmed/25300410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-014-0301-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!